To provide a clearer understanding of its pathogenesis, the role of the immune system and tumor microenvironment, as well as potential therapeutic strategies, this review summarizes current knowledge of the mechanisms and treatment challenges associated with ALK-targeted drug resistance in lung cancer. Here, ALK is linked to neoplasm.